Identifying Current Lab Trends from Labcorp & Quest Experience

By Robert Michel | From the Volume XXXI, No. 11 – August 12, 2024 Issue

CEO SUMMARY: Many different factors influence the operations of clinical laboratories in the United States today. One good source of competitive business intelligence is for lab administrators to follow the quarterly earnings calls of the nation’s two biggest public lab corporations. Wi…

Read More

---

February 26, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 3 – February 26, 2024 Issue

Following an investment of $1.75 million, officials at University of Maine at Augusta (UMA) opened a new lab facility this month that allows it to double the number of medical laboratory technicians it can train, from eight to 10 to as many as 20. In its coverage of the new training …

Read More

---

Year’s Top 10 Lab Stories Contain Surprises & Twists

By Robert Michel | From the Volume XXX, Number 18 – December 26, 2023 Issue

CEO SUMMARY: With the SARS-CoV-2 pandemic now in the rearview mirror of the nation’s clinical labs and pathology groups, the important news stories of 2023 were mostly about developments where the consequences will influence laboratory operations in coming years. Artificial intelligence…

Read More

---

Dartmouth Health Lab Recruits and Trains More CLSs

By Scott Wallask | From the Volume XXX, No. 10 – July 10, 2023 Issue

CEO SUMMARY: Keeping clinical laboratories fully staffed may be the single biggest issue confronting labs today. In New Hampshire, the lab team at Dartmouth Health crafted an innovative program that pays students as they pursue their clinical laboratory scientist certification. In…

Read More

---

‘Lab Workforce Crisis Takes Top Spot’–CAP Today

By Robert Michel | From the Volume XXIX, No. 6 – April 25, 2022 Issue

CEO SUMMARY: Just weeks ago, CAP Today characterized the current crisis in staffing clinical laboratories as going “from simmer to rolling boil.” Demand for medical technologists and other certified laboratory scientists far exceeds the supply. Consequently, many labs now…

Read More

---

Attention All Lab Professionals: It’s Time to Act!

By R. Lewis Dark | From the Volume XXIV No. 14 – October 9, 2017 Issue

AT THIS MOMENT, THE ENTIRE CLINICAL LABORATORY INDUSTRY STANDS on the precipice of the most financially disruptive development in the past three decades. On Jan. 1, the federal Centers for M…

Read More

---

New Business Models for Pathology, Clinical Labs

By R. Lewis Dark | From the Volume XXIV No. 7 – May 15, 2017 Issue

EXPERTS OFTEN PROCLAIM THAT THE U.S. HEALTHCARE SYSTEM is slow to change and slow to adopt the management approaches, operational innovations, and new technologies that other industries use. One example is adoption of the quality management techniques that W. Edwards Deming and the Japanese develope…

Read More

---

Diagnostic Error Rate Of 21% Revealed By Mayo Clinic Study

By Joseph Burns | From the Volume XXIV No. 6 – April 24, 2017 Issue

CEO SUMMARY: Researchers at the Mayo Clinic showed that only 12% of patients referred to Mayo physicians for a second opinion got a confirmation that their original diagnosis was complete and correct. In 21% of the cases, the diagnosis was completely changed. Among patients who got additi…

Read More

---

ARUP Laboratories Earns CAP’s ISO 15189 Accreditation

By Joseph Burns | From the Volume XXIV No. 5 – April 3, 2017 Issue

CEO SUMMARY: Being accredited to this internationally recognized standard for quality and competence communicates to clients and prospective clients that one of the nation’s largest clinical labs is committed to the highest standards of quality. Clients already knew about that commitmen…

Read More

---

Health System Lab Is Genotyping To Identify Best Drugs for Patients

By Joseph Burns | From the Volume XXIV No. 2 – January 30, 2017 Issue

CEO SUMMARY: One essential element of precision medicine will be the regular use of pharmacogenomic testing to provide additional guidance to physicians when selecting the most appropriate therapeutics and optimal dose for each individual patient. Despite the reluctance of private payers …

Read More

---